Click on headlines below to download research

A licensing deal for Pascomer
AFT Pharmaceuticals | 10/07/2019

AFT Pharmaceuticals has reported a North American licensing deal for Pascomer, a topical formulation of rapamycin being developed for facial angiofibromas…

Operating profitability achieved
AFT Pharmaceuticals | 28/05/2019

AFT Pharmaceuticals recently reported its FY19 results; the highlights were improving margins, as well as operating profitability for the year. Revenue…

Margins improving
AFT Pharmaceuticals | 30/11/2018

AFT Pharmaceuticals recently reported its H119 results. Operating revenue grew 4.1% compared to H118 and was negatively affected by the divestment of relatively…